What In The World Is Going On With Jaguar Health (JAGX) Stock?

Jaguar Health Inc JAGX shares are trading higher by 53.7% to $0.09, despite a lack of company-specific news for the session. The company last Friday provided an update on its listing status with the Nasdaq Stock Market. The company requested a hearing to appeal a potential delisting of its securities from Nasdaq, which has been scheduled.

Despite the potential delisting, Jaguar’s common stock will continue to trade on Nasdaq under the symbol ‘JAGX’ pending the outcome of the appeal process. The company was notified by Nasdaq in May 2023 that its stock bid price had closed below the required $1.00 per share for continued listing.

A grace period was granted until May 6, to regain compliance. However, as of February 14, the closing bid price fell to $0.10 or less for 10 consecutive trading days, triggering Nasdaq’s “Low Priced Stocks Rule” and the intention to delist Jaguar’s securities on February 26, unless the company appeals before the Nasdaq Hearings Panel.

There’s no assurance that the company will obtain an extension period to regain compliance.

See Also: Elon Musk Sues Sam Altman And OpenAI

How To Buy JAGX Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Jaguar Health’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, JAGX has a 52-week high of $1.83 and a 52-week low of $0.05.